| Further evidence of the increased risk for malignant peripheral nerve sheath tumour from a Scottish cohort of patients with neurofibromatosis type 1. | |
| | |
MedLine Citation:
|
PMID: 17327286 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
A recent study, looking at the lifetime risk of developing malignant peripheral nerve sheath tumour (MPNST) in patients with neurofibromatosis type 1 (NF1), estimated the risk to be 8-13%. Prior to this, longitudinal studies had shown that patients with NF1 had a risk of 4-5% of developing MPNST, and cross-sectional studies had found that only 1-2% of patients with NF1 had MPNST. The aim of this study was to estimate the lifetime risk of MPNST in patients with NF1 in southern Scotland, using patient records obtained from the Edinburgh and Glasgow Genetic Units and Scottish Cancer Register. In the period 1993-2002, 14 patients with NF1 were diagnosed with MPNST in a population of 3.5 million. The lifetime risk of MPNST in the Scottish patients with NF1 was calculated to be 5.9-10.3%. This provides further evidence that patients with NF1 are at greater risk of developing MPNST than was previously estimated, and emphasises the importance of educating patients about suspicious symptoms, which may need an urgent medical opinion. The mean age at diagnosis of MPNST (p<0.05) and 5-year survival (p<0.01) were significantly lower in patients with NF1 than in unaffected individuals. This may be due to patients with NF1 presenting later, because the tumour is mistaken for a neurofibroma, or due to MPNST having a more aggressive course in NF1. |
| | |
Authors:
|
J A McCaughan; S M Holloway; R Davidson; W W K Lam |
Related Documents
:
|
10898046 - Phenotypic alterations of recruited eosinophils in peritoneal fluid eosinophilia. 7526666 - Gastric acid and histamine secretion in patients on continuous ambulatory peritoneal di... 20502046 - Peritoneal protein transport during the baseline peritoneal equilibration test is an ac... 2733616 - Urban envenomation. 1342916 - Hereditary angioedema type ii--a study of two families. 9776216 - Prevention and management of central venous catheter thrombosis. |
Publication Detail:
|
Type: Comparative Study; Letter Date: 2007-02-27 |
Journal Detail:
|
Title: Journal of medical genetics Volume: 44 ISSN: 1468-6244 ISO Abbreviation: J. Med. Genet. Publication Date: 2007 Jul |
Date Detail:
|
Created Date: 2007-07-02 Completed Date: 2008-03-06 Revised Date: 2010-09-14 |
Medline Journal Info:
|
Nlm Unique ID: 2985087R Medline TA: J Med Genet Country: England |
Other Details:
|
Languages: eng Pagination: 463-6 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Humans Incidence Nerve Sheath Neoplasms / epidemiology*, etiology*, mortality Neurofibromatosis 1 / complications*, epidemiology* Risk Assessment Scotland / epidemiology Survival Analysis |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer).
Next Document: Analysis of sex chromosome abnormalities using X and Y chromosome DNA tiling path arrays.